THE new Range Rover is making its way to Mzansi.
It is expected to deliver peerless refinement and comfort of a luxury sedan with the all-conquering off-road capability and command driving position that have been its characteristics for more than 50 years.
The flagship of the Land Rover family represents the pinnacle of refined capability, thanks to advanced hardware and software systems working in harmony.
This unrivalled breadth of dynamic capability is governed by Land Rover’s integrated chassis control system while its suite of advanced technologies tailors the SUV to suit every kilometre with a network of sensors to pre-emptively and reactively fine-tune the driving characteristics.
The new flow-formed alloy wheels have been carefully engineered to reduce weight and, as a result, the new larger alloys provide no increase in mass over the previous 22-inch designs.
This contributes to the supreme ride comfort and control provided by the suspension.
Its fully-independent air suspension isolates the cabin from surface flaws more effectively than ever before, and combines industry-leading air spring volumes with twin-valve monotube dampers.
These are all managed by in-house-developed next generation adaptive dynamics control software for serene composure at all times.
The intelligent pre-emptive electronic air suspension uses eHorizon navigation data and a network of sensors to read surroundings and prepare the car for any outcome.
The New Range Rover is the first Land Rover to have undergone virtual simulator testing to perform initial prototype testing.
Over the last three years, Land Rover engineers have matched Formula 1 levels of simulator use and virtual development, even mapping local roads as part of the process.
They have invested more than 140 000 hours of analysis prior to physical testing, reducing the number of real-world development kilometres required by the fleet of physical prototypes.
The new Range Rover will go on sale in South Africa in 2022, when final prices and specifications will be confirmed.